PRESCOTT GENERAL PARTNERS LLC – Lineage Cell Therapeutics, Inc. Transaction History
PRESCOTT GENERAL PARTNERS LLC portfolio value:
$2.09M
portfolio value
PRESCOTT GENERAL PARTNERS LLC quarter portfolio value change:
-28.48%
quarter
Lineage Cell Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -833K | $1.13 | 1.85M | |
| Q2 2022 | share | 0.00% | 0 shares | 74K | $1.58 | 1.85M | |
| Q1 2022 | share | 0.00% | 0 shares | -1.68M | $1.54 | 1.85M | |
| Q4 2021 | share | 0.00% | 0 shares | -130K | $2.5 | 1.85M | |
| Q3 2021 | share | 0.00% | 0 shares | -611K | $2.52 | 1.85M | |
| Q2 2021 | share | 0.00% | 0 shares | 926K | $2.85 | 1.85M | |
| Q1 2021 | share | 0.00% | 0 shares | 1.09M | $2.35 | 1.85M | |
| Q4 2020 | share | 0.00% | 0 shares | 1.52M | $1.76 | 1.85M | |
| Q3 2020 | share | 0.00% | 0 shares | 123K | $0.94 | 1.85M | |
| Q2 2020 | share | 0.00% | 0 shares | 77K | $0.87 | 1.85M | |
| Q1 2020 | share | 0.00% | 0 shares | -114K | $0.83 | 1.85M | |
| Q4 2019 | share | 0.00% | 0 shares | -167K | $0.89 | 1.85M | |
| Q3 2019 | share | Increase | 0.00% | 1.85M shares | 1.81M | $0.98 | 1.85M |